$0.384
-0.009[-2.29%]
At close: May 22
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
11/09/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | — | $21.66M | Get Alert |
08/09/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $21.66M | Get Alert |
05/11/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $21.66M | Get Alert |
04/28/2023 | AGRX | Agile Therapeutics | Q1 | 2023 | — | — | — | $3.80M | $4.00M | $3.40M | Get Alert |
04/28/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $21.66M | Get Alert |
03/22/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $20.26M | Get Alert |
01/09/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $20.26M | Get Alert |
01/14/2021 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $1.00M | $1.00M | $1.01M | Get Alert |
11/12/2020 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $1.00M | $1.00M | $1.65M | Get Alert |
09/21/2020 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $1.00M | $2.00M | — | Get Alert |
08/11/2020 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $1.00M | $2.00M | — | Get Alert |
05/05/2020 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $4.00M | $6.00M | — | Get Alert |
There have been no specific sales or earnings guidance reported for Agile Therapeutics in recent months.
Browse guidance and forecast on all stocks.